Heartsciences Inc. Announces Conversion of Preferred Shares and Debt Exchange, Issuing Over 2.6 Million Shares of Common Stock
HeartSciences Inc. has announced a significant financial update involving the conversion of preferred shares and a debt exchange. As of September 5, 2025, the company reported the receipt of $5.4 million in gross proceeds from its Regulation A Offering, leading to the issuance of 1,556,409 units. Notably, holders of 1,054,549 shares of Series D Preferred Stock have opted to convert their shares into common stock. Additionally, HeartSciences has successfully exchanged $1,805,000 of an unsecured promissory note for 506,348 shares of common stock, effectively reducing the principal amount of the note. Consequently, the total number of common stock shares issued and outstanding now stands at 2,654,540. These strategic financial maneuvers aim to strengthen the company's capital structure and enhance its financial flexibility.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartsciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001468492-25-000006), on September 08, 2025, and is solely responsible for the information contained therein.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。